Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | BOLTBolt Biotherapeutics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $7.70M |
| Revenue, yoy | +0.1% |
| Net income | $33.38M |
| Net income, yoy | +47.1% |
| Net margin | -433.7% |
| Free cash flow | $39.92M |
| FCF margin | -518.8% |
| EPS, diluted | $17.40 |
Add another company.